Advancing human in vitro pulmonary disease models in preclinical research: opportunities for lung-on-chips: opportunities for lung-on-chips

Arbel Artzy-Schnirman; Claus-Michael Lehr; Josue Sznitman

doi:10.1080/17425247.2020.1738380

Advancing human in vitro pulmonary disease models in preclinical research: opportunities for lung-on-chips: opportunities for lung-on-chips

Arbel Artzy-Schnirman, Claus-Michael Lehr, Josue Sznitman

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	621-625
Number of pages	5
Journal	Expert Opinion on Drug Delivery
Volume	17
Issue number	5
DOIs	https://doi.org/10.1080/17425247.2020.1738380
State	Published - 3 May 2020

Keywords

Preclinical research
lung diseases
microfluidics
organ-on-chips
respiratory therapy

ASJC Scopus subject areas

Pharmaceutical Science

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/17425247.2020.1738380

Cite this

@article{d97e6eb81cd64a7aa7f80e2414be3729,

title = "Advancing human in vitro pulmonary disease models in preclinical research: opportunities for lung-on-chips: opportunities for lung-on-chips",

keywords = "Preclinical research, lung diseases, microfluidics, organ-on-chips, respiratory therapy",

author = "Arbel Artzy-Schnirman and Claus-Michael Lehr and Josue Sznitman",

note = "Funding Information: This work was supported by the German Israel Foundation (GIF, grant agreement no. I-1348-409.10/2016) and the European Research Council (ERC) under the European Union?s Horizon 2020 research and innovation program (grant agreement No 677772).",

year = "2020",

month = may,

day = "3",

doi = "10.1080/17425247.2020.1738380",

language = "אנגלית",

volume = "17",

pages = "621--625",

number = "5",

}

TY - JOUR

T1 - Advancing human in vitro pulmonary disease models in preclinical research: opportunities for lung-on-chips

T2 - opportunities for lung-on-chips

AU - Artzy-Schnirman, Arbel

AU - Lehr, Claus-Michael

AU - Sznitman, Josue

N1 - Funding Information: This work was supported by the German Israel Foundation (GIF, grant agreement no. I-1348-409.10/2016) and the European Research Council (ERC) under the European Union?s Horizon 2020 research and innovation program (grant agreement No 677772).

PY - 2020/5/3

Y1 - 2020/5/3

KW - Preclinical research

KW - lung diseases

KW - microfluidics

KW - organ-on-chips

KW - respiratory therapy

UR - http://www.scopus.com/inward/record.url?scp=85081729367&partnerID=8YFLogxK

U2 - 10.1080/17425247.2020.1738380

DO - 10.1080/17425247.2020.1738380

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.editorial???

SN - 1742-5247

VL - 17

SP - 621

EP - 625

JO - Expert Opinion on Drug Delivery

JF - Expert Opinion on Drug Delivery

IS - 5

ER -

Advancing human in vitro pulmonary disease models in preclinical research: opportunities for lung-on-chips: opportunities for lung-on-chips

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this